| Alzheimer's References |
|
[1]
Beers M and Berkow R. 2004.
Merck Manual 17th Ed. Chapter
171
[2]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[3]Beers
M and Berkow R. 2004. Merck
Manual 17th Ed. Chapter 171
[4]
Beers M and Berkow R. 2004.
Merck Manual 17th Ed. Chapter
171
[5]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[6]
Beers M and Berkow R. 2004.
Merck Manual 17th Ed. Chapter
171
[7]
Beers M and Berkow R. 2004.
Merck Manual 17th Ed. Chapter
171
[8]
Beers M and Berkow R. 2004.
Merck Manual 17th Ed. Chapter
171
[9]
Beers M and Berkow R. 2004.
Merck Manual 17th Ed. Chapter
171
[10]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[11]
Ahlemeyer B and Krieglstein J.
Pharmacological studies
supporting the therapeutic use
of Ginkgo Biloba extract for
Alzheimer's disease.
Pharmacopsychiatry 2003 Jun;
36(S1):s8-14.
[12]
Smith JV and Luo Y. Elevation of
oxidative free radicals in
Alzheimer's disease models can
be attenuated by Ginkgo biloba
extract EGb761. J Alzheimers
Dis. 2003 Aug; 5(4): 287-300.
[13]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[14]
Zangara A. The
psychopharmacology of huperzine
A: an alkaloid with cognitive
enhancing and neuroprotective
properties of interest in the
treatment of Alzheimer's
Disease. Pharmacol Biochem Behav.
2003 June; 75(3): 675-686.
[15]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[16]
Vina J et al. Molecular bases of
the treatment of Alzheimer's
Disease with antioxidants:
prevention of oxidative stress.
Mol Aspects Med. 2004 Feb-Apr;
25(1-2): 117-123.
[17]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[18]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[19]
McCaddon A et al. Functional
vitamin B12 deficiency and
Alzheimer's disease. Neurology
2002 May 14; 58(9): 1395-1399.
[20]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[21]
Mimori Y et al. Thiamine therapy
in Alzheimer's disease. Metab
Brain Dis. 1996 Mar; 11(1):
89-94.
[22]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[23]
Morris et al. Dietary niacin and
the risk of incident of
Alzheimer's disease and of
cognitive decline. J Neuro
Neurosurg Psychiatry 2004 Aug;
75(8): 1093-1099.
[24]
McDaniel MA et al. Brain
specific nutrients: a memory
cure? Nutrition 2003 Nov-Dec;
19(11-12): 957-975.
[25]
Conant R and Schauss A.
Therapeutic applications of
citicoline for stroke and
cognitive dysfunction in the
elderly: a review of the
literature. Alternative Med Rev.
2004; 9(1): 17-31.
[26]
McDaniel MA et al. Brain
specific nutrients: a memory
cure? Nutrition 2003 Nov-Dec;
19(11-12): 957-975.
[27]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[28]
Pizzorno J, Murray M, and
Joiner-Bey H. The Clinician's
Handbook of Natural Medicine.
Pp: 28-34. Churchill Livingstone
New York.
[29]
McDaniel MA et al. Brain
specific nutrients: a memory
cure? Nutrition 2003 Nov-Dec;
19(11-12): 957-975.
[30]
Bianchetti A et al. Effects of
acetyl-l-carnitine in
Alzheimer's disease patients
unresponsive to
acetylcholinesterase inhibitors.
Curr Med Res Opin. 2003; 19(4):
350-353.
[31]
Cooper JL. Dietary lipids in the
aetiology of Alzheimer's
disease: implications for
therapy. Drugs Aging 2003;
20(6): 399-418.
|